Experiments were designed to determine the endothelium-dependent and endothelium-independent responses to aggregating platelets in porcine pulmonary arteries. Isolated rings with and without endothelium from large (5-7-mm-diameter) and small (2-3-mm-diameter) pulmonary arteries were suspended in modified Krebs-Ringer bicarbonate solution bubbled with 95% 02-5% CO2 in the presence of indomethacin. Aggregating platelets caused relaxations in rings with endothelium but contractions in rings without endothelium, both of which were significantly larger in small versus large pulmonary artery rings. Serotonin and ADP caused concentration-dependent endothelium-augmented relaxations that were unaffected by ketanserin. Methiothepin, but not apyrase, significantly decreased the platelet-induced endotheliumdependent relaxations; the residual relaxation was abolished when rings were incubated with methiothepin, apyrase, and theophylline but was unaffected if apyrase was absent, indicating that ADP is responsible for the residual relaxation caused by aggregating platelets. Quiescent rings, with and without endothelium, contracted in a dose-dependent manner to norepinephrine and histamine but not to serotonin or vasopressin. The contraction to aggregating platelets was blocked by methiothepin, pyrilamine, and diphenhydramine but was unaffected by phentolamine, ketanserin, or incubation of the platelets with dazoxiben. These data indicate that, in large and small porcine pulmonary arteries, serotonin and ADP are the major contributors to the endothelium-dependent relaxation caused by aggregating platelets, while histamine appears to be responsible for the contraction that platelets cause in rings without endothelium. (Circulation Research 1991;68:1437-1445 
Heterogeneit of Endothelium Experiments were designed to determine the endothelium-dependent and endothelium-independent responses to aggregating platelets in porcine pulmonary arteries. Isolated rings with and without endothelium from large (5-7-mm-diameter) and small (2-3-mm-diameter) pulmonary arteries were suspended in modified Krebs-Ringer bicarbonate solution bubbled with 95% 02-5% CO2 in the presence of indomethacin. Aggregating platelets caused relaxations in rings with endothelium but contractions in rings without endothelium, both of which were significantly larger in small versus large pulmonary artery rings. Serotonin and ADP caused concentration-dependent endothelium-augmented relaxations that were unaffected by ketanserin. Methiothepin, but not apyrase, significantly decreased the platelet-induced endotheliumdependent relaxations; the residual relaxation was abolished when rings were incubated with methiothepin, apyrase, and theophylline but was unaffected if apyrase was absent, indicating that ADP is responsible for the residual relaxation caused by aggregating platelets. Quiescent rings, with and without endothelium, contracted in a dose-dependent manner to norepinephrine and histamine but not to serotonin or vasopressin. The contraction to aggregating platelets was blocked by methiothepin, pyrilamine, and diphenhydramine but was unaffected by phentolamine, ketanserin, or incubation of the platelets with dazoxiben. These data indicate that, in large and small porcine pulmonary arteries, serotonin and ADP are the major contributors to the endothelium-dependent relaxation caused by aggregating platelets, while histamine appears to be responsible for the contraction that platelets cause in rings without endothelium. (Circulation Research 1991;68:1437-1445) A ggregating porcine platelets release a variety of vasoactive substances, among which are 5 -hydroxytryptamine (serotonin), ADP, thromboxane A2, histamine, vasopressin, and catecholamines.1'2 The endothelium inhibits contractions to aggregating platelets in canine and porcine coronary arteries but does not do so in canine pulmonary arteries, where aggregating platelets cause contractions in vessels with and without endothelium. [2] [3] [4] [5] [6] Microembolization and in situ aggregation of platelets have been implicated in pulmonary vascular constriction and pulmonary hypertension through the release of vasoactive mediators.7-13 The present study (5) (6) (7) mm in diameter) and small (2-3 mm in diameter) pulmonary arteries were cleaned of connective tissue, with special care taken not to touch the luminal surface. In some rings, the endothelium was deliberately removed by gently rubbing the luminal surface with either a cotton swab wetted with control solution (large rings) or a thin (0.3 mm) wire (small rings). The rings were mounted horizontally between a fixed stirrup and a force transducer (model UTC2, Gould Inc., Cleveland, Ohio) in an organ chamber filled with 25 ml control solution that was bubbled with 95% 02-5% CO2 and maintained at 37°C, and isometric tension was recorded. The rings were then allowed to equilibrate for 30-40 minutes before further experimentation. Rings with and without endothelium from large and small arteries were studied in parallel.
Platelets
Autogenous blood (300-500 ml) was drawn from the left carotid artery of the pig into 50-ml plastic syringes filled with 5-6 ml citrate anticoagulant to yield final concentrations (mM) of sodium citrate 9.3, citric acid 0.7, and dextrose 14. The blood was centrifuged at 750 rpm at room temperature, and the platelet-rich plasma was pipetted into plastic test tubes. An equal volume of cold citrate anticoagulant solution containing (mM) sodium citrate 93, citric acid 7, dextrose 105, and KCl 5 brought to a pH of 6.5 was added to the platelet-rich plasma and centrifuged at 1,600 rpm. The supernatant was discarded, and the remaining platelet pellet was resuspended in a small volume (1/40 of the original blood volume) of the second citrate anticoagulant solution. A platelet count of this suspension was obtained (Coulter Electronics, Inc., Hialeah, Fla.), and the volume of the suspension was adjusted so that, when it was added to the organ chamber, the resulting platelet concentrations in the organ bath were 25,000/,ul, 50,000/,ul, and 75,000/,l. Platelet aggregation on exposure to the collagen within the blood vessel wall and the calcium-containing control solution was evidenced by clearing of the initially turbid solution, formation of visible platelet clumps, and detectable levels of serotonin, histamine, and thromboxane B2 in the bath solution.
In some studies, the platelets were incubated in the presence of dazoxiben (6 x 10`M, a selective inhibitor of thromboxane A2 synthetase) for 60 minutes before addition to the organ bath. A comparable concentration of dazoxiben (10`4 M) in the organ bath did not cause a change in tension in the quiescent rings (data not shown). Samples of fluid (2 ml) for the determination of serotonin, histamine, and thromboxane B2 were drawn from the chambers 10 minutes after the addition of platelets, and frozen until analysis. Protocol After equilibration, rings were incubated with indomethacin (10-5 M) for at least 30 minutes. In quiescent rings, with and without endothelium, concentration-response curves to histamine (10`9 to 10`t To delineate the relative contributions of the vasoactive substances released from aggregating platelets to the relaxation evoked by the platelets, rings with endothelium were first incubated with several selective and nonselective antagonists for 40 minutes before their exposure to increasing concentrations of the platelets. The antagonists used were methiothepin, a combined 5-HT1-and 5-HT2-serotonergic antagonist; ketanserin, a selective 5-HT2-serotonergic antagonist; apyrase, an ADPase and ATPase; theophylline (10-4 M), a purinergic P1-receptor blocker and phosphodiesterase inhibitor; rolipram (5x 10-6 M), a phosphodiesterase inhibitor without purinergic antagonist activity; cimetidine (10-6 M), a selective H2-histaminergic antagonist; phentolamine (10-5 M) and propranolol (5 x 10-6 M), to block a-and 13-adrenergic activity; and combinations of methiothepin and apyrase and/or theophylline and/or rolipram and/or cimetidine. Apyrase sometimes caused a transient relaxation that lasted 30-60 seconds; platelets were added only after the tension returned to its previously contracted level. The presence or absence of the endothelium was confirmed by the presence or absence of relaxation to bradykinin (1O-`M).
Drugs
The following drugs were used: adenosine, ADP, apyrase (ATPase and ADPase, grade V from potato), arginine-vasopressin, bradykinin, diphenhydramine hydrochloride, histamine, indomethacin, L-phenylephrine, DL-propranolol, prostaglandin F2a, pyrilamine maleate, 5 -hydroxytryptamine creatinine sulfate (serotonin), sodium nitroprusside, theophylline, and thrombin (Sigma Chemical Co., St. Louis); dazoxiben hydrochloride (Pfizer Laboratories, New York); ketanserin tartrate (Janssen Pharmaceutica, Beerse, Belgium); methiothepin maleate (Roche Laboratories, Nutley, N.J.); phentolamine (CIBA-GEIGY Co., Summit, N.J.); and rolipram (Berlex Laboratories, Inc., Wayne, N.J.). All drugs were prepared daily using distilled water. Indomethacin was dissolved with Na2C03 (10-5 M) . Apyrase was prepared with distilled water immediately before addition to the organ chamber in a concentration of 75 units ADPase and 75 units ATPase activity per 25 ml (1 unit activity liberates 1 mol POQ4min). Drugs were kept on ice and platelets were kept at room temperature during the experiments. Drug concentrations are expressed as final molar concentrations in the organ bath; apyrase is expressed as unit activity of ADPase per milliliter of organ bath solution.
Serotonin
Immediately after the experiment, 0.5 ml fluid collected from the organ bath was added to 120 gl cysteine (1% solution), and proteins were precipitated by adding ZnSO4 and NaOH. This solution was centrifuged at 1,400g for 30 minutes. The supernatant was decanted and frozen at -70°C until analysis. Analysis was performed by filtering the supernatant through centrifugal microfilters (Bioanalytical Systems, West Lafayette, Ind.) with regenerated cellulose membranes (pore size, 0.1 gm). The amine was quantitated by reversed-phase high-pressure liquid chromatography with electrochemical detection.14 The interassay coefficient of variation was 5.6%.
Thromboxane B2
Fluid (2 ml) from the organ bath was collected immediately after the experiment and frozen (-70°C) until analysis. curve. The recovery of the cold standard averaged 94%. The interassay coefficient of variation was 5.6%, and the interassay variation was 9.6%.
Histamine
The histamine standards for the assay (62-989 ng/ml) were freshly prepared by diluting histamine phosphate (Sigma) in Krebs' solution. These standards ("internal standards") were carried through the entire extraction process with the unknown samples. A 1-ml sample of standard or test solution was added to 13 x 100-mm glass tubes containing 300 mg NaCl and 1.25 ml butanol, and while the tubes were vortexed, 0.1 ml of 3N NaOH was added, and the tubes were vortexed for an additional 2 minutes. After centrifugation for 5 minutes at 1,800 rpm, 1 ml of the butanol layer was transferred to tubes containing 0.7 ml of 0.12N HCl and 2 ml heptane, and the tubes were vortexed for 1 minute, then allowed to remain in the cold room overnight. The HCl layer (0.6 ml) was transferred to 10x75-mm glass tubes, to which were then added 0.25 ml of 0.75N NaOH and 0.075 ml o-phthalaldehyde solution (3 mg in 4.5 ml methanol), and the tubes were vortexed briefly and incubated in an ice bath for 40 minutes. The reaction was stopped by addition of 0.12 ml of 1.25 M phosphoric acid, after which the tubes were again vortexed and allowed to warm to room temperature. Tubes were read in a fluorometer at an excitation wavelength of 450 nm. The reading given by Krebs' solution alone (blank) was subtracted from the reading given by unknown samples. The efficiency of extraction and conjugation of the histamine was calculated to be 50%, as measured by "external standards" of histamine in 0.12N HCl that were not carried through the extraction process. 16 
Statistical Analysis
Results are expressed as mean±SEM. For platelet-induced contractions in quiescent rings without endothelium, the maximal contraction is expressed as a percentage of the contraction evoked by 20 
Results

Platelets
In quiescent preparations, rings without endothelium contracted in response to aggregating platelets. The contractions were significantly larger in small compared with large arterial rings (Figure 1 ). Rings with endothelium did not contract in response to aggregating platelets, but rather exhibited no change or a decrease in tension. Quiescent rings without endothelium incubated with ketanserin or phentolamine and propranolol exhibited contractions similar to those observed in control rings. Methiothepin, pyrilamine, and diphenhydramine inhibited the contractions to aggregating platelets. Platelets incubated with dazoxiben, a thromboxane A2 synthetase inhibitor, caused contractions similar to those in control rings (Figure 2) .
Aggregating platelets caused endothelium-dependent relaxations that were larger in small compared with large arterial rings (Figure 3) . Incubation of the rings with ketanserin did not alter the magnitude of the relaxation (data not shown). Incubation of the rings with methiothepin and apyrase significantly lessened but did not abolish the relaxations, whereas relaxations in rings incubated with apyrase alone were not significantly different from relaxations in control rings (Figure 4 ). The addition of cimetidine to methiothepin or the combination of propranolol and phentolamine did not further reduce the relaxation (data not shown). Theophylline in combination with methiothepin and apyrase nearly abolished the platelet-induced relaxation, whereas the combination of rolipram, methiothepin, and apyrase did not cause a similar reduction in relaxation (Figure 4 ).
Serotonin
Serotonin caused endothelium-augmented relaxations that were larger in small compared with large arterial rings ( Figure 5 , left panel; Table 1 ). Incubation with ketanserin did not change the magnitude of Platelets, perpL FIGURE 3. Concentration-response curve to aggregating platelets in large (5-7mm in diameter) and small (2-3 mm in diameter) porcine pulmonary arteries with and without endothelium. Rings were contracted with prostaglandin F2a (2-4x1 'M) to a contraction equal to 40 -60% ofthe maximal norepinephrine contraction. Data are shown as mean ±SEM.
All experiments were perfonned in the presence of indomethacin (10-5 M). W: l00 quiescent rings with or without endothelium in both large and small pulmonary arteries.
Adenosine
Adenosine caused concentration-dependent relaxations in rings with and without endothelium (100% relaxation in all rings studied, n =4) that were attenuated significantly (maximal relaxation observed= 30% of the prostaglandin contraction) in rings incubated with theophylline, a P1-purinoceptor blocker ( Figure 7) . The tractions evoked by histamine, whereas phentolamine plus propranolol and ketanserin had no effect on the contractile response (data not shown). Thrombin Increasing concentrations of thrombin caused dose-dependent decreases in tension in rings with, but not in those without, endothelium. Rings denuded of endothelium exhibited contractions to thrombin (Figure 8 ).
Vasopressin
Arginine vasopressin caused endothelium-dependent relaxations, but only at 106 M. No change in tension was observed in quiescent rings (data not shown). Sodium Nitroprusside Sodium nitroprusside caused relaxations in large and small arterial rings, with and without endothelium, that were similar in magnitude (ED50 [-log M±SEM]: small, -7.51+0.10; large, -7.43+±0.16). Products Released From Aggregating Platelets Aggregating platelets released serotonin, thromboxane A2, and histamine into the bath solution. The concentration of serotonin (n =6) detected averaged 180+ 117 ng/ml (5x 10-6 M), while that of thromboxane (n=8) was 57 pg/ml or less (1.5x 10`'°M). Histamine was detected in concentrations of 234±107 ng/ml (1.3 x 10-6 M, n = 18). Adenosine diphosphate,-iogM Discussion The present study demonstrates that 1) the endothelium reduces the contraction of pulmonary vascular smooth muscle evoked by the vasoconstrictor mediators released from aggregating platelets; 2) in the absence of endothelium, platelets cause contractions of porcine pulmonary arteries and plateletderived histamine contributes importantly to the contraction; and 3) platelet-induced relaxations and contractions are more pronounced in distal than in proximal pulmonary arteries.
In the porcine pulmonary arteries aggregating platelets caused endothelium-dependent relaxations that appear to be mediated by serotonin and ADP as in canine and porcine coronary arteries.2-5 Indeed, although the serotonin and platelet-induced relaxations are unaffected by ketanserin (a selective 5HT2-serotonergic antagonist), they were significantly inhibited by methiothepin, a nonselective 5HT, and 5HT2 antagonist, suggesting that 5HT1-serotonergic receptors are implicated in the platelet-induced response.17-'9 A similar conclusion has been reached for porcine coronary arteries and other blood vessels from other species. (the stable metabolite of thromboxane A2) detected in the organ bath solution. However, platelet-induced contractions in this preparation were inhibited by three H1-histaminergic antagonists, implicating histamine in the contraction by activating H,-histaminergic receptors. The magnitude of the contractions induced by platelets is comparable to the level of contraction caused by the concentrations of histamine found in the organ bath solution. Although not thought to play a predominant role in the plateletinduced contractions in other porcine vessels, a partial role for histamine in the platelet-induced contraction has been described for porcine coronary arteries. ' The relaxations and contractions caused by aggregating platelets observed in this study were significantly larger in the smaller, more distal pulmonary arteries. Previous work described larger relaxations in smaller vessels to other endothelium-dependent vasodilators such as acetylcholine and bradykinin but not the calcium ionophore A23187, indicating that the larger relaxations are secondary to increased number or affinity of the receptors or a tighter receptor coupling mechanism in the smaller vessels and not an increased ability of the endothelium of the distal vessels to synthesize or release endothelium-derived relaxing factor.29 '30 Since the sodium nitroprusside-induced relaxations were similar in large and small arteries, it is unlikely that a difference in sensitivity of soluble guanylate cyclase or to cGMP explains the increased relaxations to platelets in the small vessels.31'32 The serotonin levels were similar in the organ chambers containing the large and small vessels; the corresponding concentration causes similar relaxations in both large and small vessels. Because the ADP-induced relaxations were larger in the small vessels at the highest concentrations, the larger relaxations observed to aggregating platelets in the smaller vessels could be explained by larger ADP-induced relaxations. This could be due to differences in number, affinity, or coupling of the purinergic receptors.29 However, a heterogeneity in the degradation or dephosphorylation of ADP by the endothelial cells in the more distal vessels is another possibility. The latter explanation would support the important role for adenosine in the relaxations evoked by aggregating platelets.
The larger contractions to aggregating platelets in the smaller vessels parallels that to histamine. Because the potassium-induced contraction (the standard against which the platelet-induced contraction was compared) was similar, any difference in the histamine-induced contraction between the two sizes of vessels could account for the difference in magnitude of the platelet-induced contractions.
Physiologically, the lungs act as a filter to circulating platelet microaggregates, helping to prevent systemic embolization. Most of these aggregates are filtered at the level of the precapillary and capillary vessels. Constriction of these vessels in response to vasoactive substances released from platelets may cause elevation of pulmonary artery pressures and resistance. Angiograms of cat lungs, which have been infused with platelet microaggregates, show tapering or a "cut off' appearance of the precapillary muscular vessels. The larger elastic vessels increased in size with the same treatment.33,34 These findings in vivo are consistent with the in vitro data obtained in this study. The musculoelastic arteries in our study dilated to the aggregating platelets. This dilation may be important in allowing the microaggregates to travel as far "downstream" as possible so as not to block a large vascular segment that would cause underperfusion of a larger segment of lung as opposed to underperfusion of the smaller cross-sectional area represented by small capillary beds. The endothelium may thus be important in protecting the lung vessels against the mechanical blockade of platelet aggregates, allowing for less ventilation and perfusion abnormalities.
